• Something wrong with this record ?

Inguinal hernia treatment in Switzerland: inpatient vs. outpatient setting - HerStAmb Study (prospective observational two-centre comparative study)

M. Ziga, L. Burla, A. Imhof, T. Gürtler, M. Weber

. 2023 ; 408 (1) : 14. [pub] 20230109

Language English Country Germany

Document type Observational Study, Journal Article

PURPOSE: Since 01/2018, AVOS (ambulant vor stationär = outpatient to inpatient) regulation has been progressively implemented in hernia surgery in Switzerland. The aim of this prospective, observational, two-centre comparative study was to compare the outcome of outpatient and inpatient post-operative care in terms of AVOS by examining the re-admission rate, complication rate and quality of life in patients with primary unilateral inguinal hernia repair. METHODS: The study ran between 01/2019 and 04/2020 and included 237 patients with a primary unilateral inguinal hernia. Treatment setting was decided according to AVOS guidelines. Primary endpoint was re-admission rate within 6 weeks postoperatively. Secondary endpoints were the complication rate and patient outcome (quality of life) at 6 weeks follow-up postoperatively, as measured by the Short Form 36 Health Survey Questionnaire (SF-36). RESULTS: Complications occurred in 11 (14%) inpatient patients, but none required re-admitting for revision until follow-up at 6 weeks after discharge. In the outpatient group, there were 27 (17%) complications reported, while 6 (4%) of these patients crossed over to the inpatient group immediately after surgery. None of the other complications required re-admission until follow-up at 6 weeks. No significant relationship between treatment setting and number of complications/re-admission rate (p=0.458, p=0.061) was observed. The mean outcome (SF-36) between the treatment groups was not significantly different (p=0.16-0.856). CONCLUSION: In terms of AVOS selection criteria in Switzerland, primary unilateral inguinal hernia can be safely treated in both treatment settings. Re-admission rates, complications and quality of life do not significantly differ. Day surgery in terms of AVOS might be as effective and efficient, both from the patient's perspective and that of the institution. TRIAL REGISTRATION NUMBER: NCT05234242.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23004636
003      
CZ-PrNML
005      
20230425171633.0
007      
ta
008      
230418s2023 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00423-023-02766-y $2 doi
035    __
$a (PubMed)36622458
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Ziga, Michal $u Department of Surgery, Cantonal Hospital Schaffhausen, Geisbergstrasse 81, CH-8208, Schaffhausen, Switzerland. michal.ziga@gmail.com $u Faculty of Medicine, University of Zurich, Zurich, Switzerland. michal.ziga@gmail.com $u 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. michal.ziga@gmail.com $1 https://orcid.org/000000018071246X
245    10
$a Inguinal hernia treatment in Switzerland: inpatient vs. outpatient setting - HerStAmb Study (prospective observational two-centre comparative study) / $c M. Ziga, L. Burla, A. Imhof, T. Gürtler, M. Weber
520    9_
$a PURPOSE: Since 01/2018, AVOS (ambulant vor stationär = outpatient to inpatient) regulation has been progressively implemented in hernia surgery in Switzerland. The aim of this prospective, observational, two-centre comparative study was to compare the outcome of outpatient and inpatient post-operative care in terms of AVOS by examining the re-admission rate, complication rate and quality of life in patients with primary unilateral inguinal hernia repair. METHODS: The study ran between 01/2019 and 04/2020 and included 237 patients with a primary unilateral inguinal hernia. Treatment setting was decided according to AVOS guidelines. Primary endpoint was re-admission rate within 6 weeks postoperatively. Secondary endpoints were the complication rate and patient outcome (quality of life) at 6 weeks follow-up postoperatively, as measured by the Short Form 36 Health Survey Questionnaire (SF-36). RESULTS: Complications occurred in 11 (14%) inpatient patients, but none required re-admitting for revision until follow-up at 6 weeks after discharge. In the outpatient group, there were 27 (17%) complications reported, while 6 (4%) of these patients crossed over to the inpatient group immediately after surgery. None of the other complications required re-admission until follow-up at 6 weeks. No significant relationship between treatment setting and number of complications/re-admission rate (p=0.458, p=0.061) was observed. The mean outcome (SF-36) between the treatment groups was not significantly different (p=0.16-0.856). CONCLUSION: In terms of AVOS selection criteria in Switzerland, primary unilateral inguinal hernia can be safely treated in both treatment settings. Re-admission rates, complications and quality of life do not significantly differ. Day surgery in terms of AVOS might be as effective and efficient, both from the patient's perspective and that of the institution. TRIAL REGISTRATION NUMBER: NCT05234242.
650    _2
$a lidé $7 D006801
650    12
$a inguinální hernie $x chirurgie $7 D006552
650    _2
$a hospitalizovaní pacienti $7 D007297
650    _2
$a pacienti ambulantní $7 D010045
650    _2
$a kvalita života $7 D011788
650    _2
$a prospektivní studie $7 D011446
650    _2
$a operace kýly $x škodlivé účinky $7 D059685
650    _2
$a recidiva $7 D012008
650    _2
$a výsledek terapie $7 D016896
650    _2
$a chirurgické síťky $7 D013526
651    _2
$a Švýcarsko $7 D013557
655    _2
$a pozorovací studie $7 D064888
655    _2
$a časopisecké články $7 D016428
700    1_
$a Burla, Laurin $u Department of Visceral-, Thoracic- and Vascular Surgery, Triemli City Hospital, Birmensdorferstrasse 497, CH-8063, Zurich, Switzerland
700    1_
$a Imhof, Adrienne $u Department of Surgery, Cantonal Hospital Schaffhausen, Geisbergstrasse 81, CH-8208, Schaffhausen, Switzerland
700    1_
$a Gürtler, Thomas $u Department of Visceral-, Thoracic- and Vascular Surgery, Triemli City Hospital, Birmensdorferstrasse 497, CH-8063, Zurich, Switzerland
700    1_
$a Weber, Markus $u Department of Visceral-, Thoracic- and Vascular Surgery, Triemli City Hospital, Birmensdorferstrasse 497, CH-8063, Zurich, Switzerland
773    0_
$w MED00005024 $t Langenbeck's archives of surgery $x 1435-2451 $g Roč. 408, č. 1 (2023), s. 14
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36622458 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230418 $b ABA008
991    __
$a 20230425171629 $b ABA008
999    __
$a ok $b bmc $g 1924994 $s 1190845
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 408 $c 1 $d 14 $e 20230109 $i 1435-2451 $m Langenbeck's archives of surgery $n Langenbecks Arch Surg $x MED00005024
LZP    __
$a Pubmed-20230418

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...